These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11183936)

  • 1. Roundtable discussion: Part III--Hypertension management in health plans.
    Penna P; Cox E; Joseph T; Lehman L; Morrow T; Richter A; Sowers J; Tepper D
    Manag Care Interface; 2000; Suppl C():24-31. PubMed ID: 11183936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roundtable discussion: Part II--Development of a pharmacoeconomic model in hypertension.
    Penna P; Cox E; Joseph T; Lehman L; Morrow T; Richter A; Sowers J; Tepper D
    Manag Care Interface; 2000; Suppl C():17-23. PubMed ID: 11183935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of pharmacoeconomic data in managed care: closing the credibility gap.
    Lewis BE
    Manag Care Interface; 1997 Nov; 10(11):99-103. PubMed ID: 10174761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roundtable discussion: Part I--Epidemiologic, demographic, and treatment challenges in hypertension.
    Penna P; Cox E; Joseph T; Lehman L; Morrow T; Richter A; Sowers J; Tepper D
    Manag Care Interface; 2000; Suppl C():10-6. PubMed ID: 11183934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weighing the evidence: trends in managed care formulary decision making.
    de Lissovoy G
    J Clin Psychiatry; 2003; 64 Suppl 17():29-32. PubMed ID: 14680425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roundtable discussion. Achieving more aggressive low-density lipoprotein cholesterol lowering.
    Hunninghake DB; McKenney JM; Gotto AM; Mehta JL; Jones PH
    Am J Manag Care; 2000 Nov; 6(19 Suppl):S1008-16. PubMed ID: 11187369
    [No Abstract]   [Full Text] [Related]  

  • 7. Implementing the new HEDIS hypertension performance measure.
    Sennett C
    Manag Care; 2000 Apr; 9(4 Suppl):2-17; quiz 18-21. PubMed ID: 11729402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of combination therapy in achieving blood pressure control.
    Neutel JM
    Am J Manag Care; 1999 Jun; 5(7 Suppl):S463-8. PubMed ID: 10538855
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of pharmacoeconomic modeling in depression management by a health plan.
    Watkins JB
    Manag Care Interface; 2003; Suppl B():22-6. PubMed ID: 12647610
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of combination therapy on managed care. Based on a presentation by Lisa Latts, MD, MSPH.
    Am J Manag Care; 1999 Jun; 5(7 Suppl):S456-60; discussion S460-2. PubMed ID: 10538854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copayment level and compliance with antihypertensive medication: analysis and policy implications for managed care.
    Taira DA; Wong KS; Frech-Tamas F; Chung RS
    Am J Manag Care; 2006 Nov; 12(11):678-83. PubMed ID: 17090224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of pharmacoeconomics to formulary decision making in managed care organizations.
    Suh DC; Okpara IR; Agnese WB; Toscani M
    Am J Manag Care; 2002 Feb; 8(2):161-9. PubMed ID: 11858228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in antihypertensive compliance by BCBSRI disease and case management intervention group.
    Kuo S; Burrill J
    Med Health R I; 2007 Dec; 90(12):381-4. PubMed ID: 18314829
    [No Abstract]   [Full Text] [Related]  

  • 14. The case for a value-based formulary: striving for total lowest net cost.
    Weart W; Bauman GR
    Manag Care Interface; 2007 Apr; 20(4):42-7. PubMed ID: 17474330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective strategies for managing pharmacy benefits.
    Jacobson D
    Healthc Financ Manage; 2001 Mar; 55(3):41-2. PubMed ID: 11258270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic value of individualizing drug therapy.
    Navarro RP
    Manag Care Interface; 1997 Oct; 10(10):96-8. PubMed ID: 10174423
    [No Abstract]   [Full Text] [Related]  

  • 17. Disease management and formulary compliance programs under the HIPAA privacy rule.
    Lutes ME
    Manag Care; 2001 Sep; 10(9 Suppl):7-8; discussion 9-12. PubMed ID: 11729440
    [No Abstract]   [Full Text] [Related]  

  • 18. Making health plans more attractive to consumers: the role of disease management programs.
    Kozma CM
    Manag Care Interface; 2002 Oct; 15(10):46-7. PubMed ID: 12391818
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic.
    Caro JJ; Lee K
    Curr Hypertens Rep; 2002 Dec; 4(6):418. PubMed ID: 12419167
    [No Abstract]   [Full Text] [Related]  

  • 20. Migraine in managed care. Based on a presentation by Delores Bowman, RN, BSN, CRM.
    Am J Manag Care; 1999 Feb; 5(2 Suppl):S99-103. PubMed ID: 10346520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.